b.jansen
TL2 Moderator · Faro
Contributes reviews on supplier material. Based in Faro.
Joined 13 May 2025 · last posted 20h
73 posts, newest first. Showing up to 150.
-
Review: a draft on reconstitution arithmetic, with objections — one year on Replied, post #52 · Documentation › Doc review · 27 Jul 2026 · 26 likes Review of promoted topics: when a topic is nominated for promotion to a maintained documentation page, the draft is posted here. Community review happens before…
-
Review: an evidence digest and the citation check that delayed it Replied, post #18 · Documentation › Doc review · 26 Jul 2026 · 17 likes This follows post #15 rather than contradicting it. Review date disputes: if a maintained page's review date is approaching and it has not been updated, post a note so…
-
Submitting a sample: the process end to end Replied, post #110 · Sourcing › Independent verification · 25 Jul 2026 · 0 likes PeptideMeter: purity analysis plus structured, dated supplier verification records. Produces both individual analytical results and verification records assessed over…
-
Tracking a shortage from primary sources rather than rumour Replied, post #118 · Access › Shortages · 23 Jul 2026 · 5 likes Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still makes sense to read. The error was mine and it was the…
-
Muscle cramps: the ordinary causes before the exotic ones — a second dataset Replied, post #66 · Practice › Side effects · 22 Jul 2026 · 23 likes Coming back to post #64, because the follow-up matters more than the original answer. Lean mass loss: the rate of lean tissue loss depends on protein intake, resistance…
-
Impurity thresholds: where the common numbers come from Replied, post #6 · Analytics › Impurities & related substances · 16 Jul 2026 · 6 likes This follows post #3 rather than contradicting it. Incomplete deprotection: mass higher by the protecting group mass. Usually markedly later eluting. A synthesis…
-
Restarting after a long gap: what the labelling implies Replied, post #25 · Practice › Dosing & titration · 14 Jul 2026 · 7 likes Titrating on tolerability rather than on the calendar: some people escalate when they tolerate a dose well, others escalate on the prescribed schedule regardless. The…
-
Prior authorisation: what the criteria usually require — a second dataset Replied, post #26 · Access › Insurance & coverage · 14 Jul 2026 · 24 likes Generic versus brand: most of these compounds do not have generic versions yet. Once they do, formulary coverage and pricing will shift.
-
Revisiting: Can a home kit substitute for a laboratory report? A careful no Replied, post #49 · Analytics › Home & field testing · 12 Jul 2026 · 18 likes False positives and false negatives: no test has 100% sensitivity and 100% specificity. A negative result does not guarantee absence; a positive result does not…
-
Coming back to: Time to steady state after a dose increase Replied, post #95 · Pharmacology › Pharmacokinetics · 7 Jul 2026 · 22 likes For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
-
[2026 update] Travelling with an injectable: documentation and practicalities Replied, post #63 · Access › International · 7 Jul 2026 · 9 likes Coming back to post #61, because the follow-up matters more than the original answer. Licensed prescribing: where a compound is approved, prescribing is restricted to…
-
Second pass at: Cost versus information: making the trade-off explicitly Replied, post #13 · Analytics › Home & field testing · 29 Jun 2026 · 0 likes Worth separating two things that post #9 runs together. Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did…
-
0.3 mL versus 0.5 mL versus 1 mL barrels: resolution matters Replied, post #86 · Devices › Syringes & needles · 27 Jun 2026 · 20 likes Sharps disposal: needles and syringes should be disposed in a sharps container (a rigid, puncture-resistant container). Do not put them in regular trash. Many…
-
Stepping down deliberately, and how to do it without losing progress — what changed since Replied, post #10 · Practice › Dosing & titration · 22 Jun 2026 · 21 likes Worth separating two things that post #6 runs together. Holding a dose indefinitely: the trials did not study indefinite holding at a non-maximum dose. The trials…
-
Comparing prices across jurisdictions without misleading yourself Replied, post #27 · Access › Pricing · 1 Jun 2026 · 10 likes Worth separating two things that post #23 runs together. International pricing: the same compound costs very different amounts in different countries because healthcare…
-
A 40-week log with the measurement method stated — what changed since Replied, post #6 · marked as the solution · Outcomes › Progress reports · 1 Jun 2026 · 7 likes post #5 answers the question as asked. The question underneath it is different. For anyone arriving from a search: the marked solution above is the direct answer, and…
-
Five questions in one post gets you one answer — how to split them Replied, post #87 · Start Here › How to Ask · 21 May 2026 · 26 likes Units. Everything needs units. This is why we ask every single time. I have seen the same arithmetic done three different ways depending on whether the person was…
-
Semaglutide and gastric emptying — the mechanism behind most of the side-effect profile Replied, post #29 · Compounds › Semaglutide · 16 May 2026 · 33 likes The STEP programme populations were selected: enrollment criteria required baseline body mass index over 30, no recent blood pressure crisis, no recent retinopathy, no…
-
Journal club: LEADER as the historical anchor Replied, post #72 · Evidence › Journal club · 10 May 2026 · 0 likes SURPASS-2 (N Engl J Med 2021): Direct comparison of tirzepatide with semaglutide 1.0 mg. The 1.0 mg dose is not the highest available, which is the central and…
-
Washout with a one-week half-life: the arithmetic — does this still hold? Replied, post #9 · Research Methods › N-of-1 designs · 22 Apr 2026 · 20 likes Sample size in n-of-1: you are the sample. Repeated measurements (weekly weighings, daily mood scores) increase the power to detect a real effect even though n=1.
-
Converting between mg/mL and units per dose, both directions — the long version Replied, post #40 · Practice › Reconstitution · 20 Apr 2026 · 2 likes A vial that will not fully dissolve: check in order: is the diluent genuinely room temperature (some preservatives crystallise in cold), is the vial being warmed gently…
-
The "under review" status pill and when a moderator applies it Replied, post #69 · Evidence › Preprints · 12 Apr 2026 · 3 likes This follows post #66 rather than contradicting it. Always label it as a preprint in any discussion. A preprint is not a published trial and it is not settled…
-
Bug report: the reconstitution calculator and a rounding edge case Replied, post #55 · Data & Tools › Calculators · 9 Apr 2026 · 27 likes Storage lookup: which conditions (temperature, time) are you considering storing in, and how much stability loss is expected? The calculator gives a rough estimate…
-
Spike-and-recover accuracy for a peptide assay Replied, post #54 · Analytics › Method validation · 8 Apr 2026 · 0 likes For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
-
[2026 update] Charge states for a 4 kDa peptide, worked through Replied, post #52 · Analytics › Mass spectrometry · 3 Apr 2026 · 29 likes post #51 is right about the mechanism and I think understates the practical bit. Calibration matters: a high-resolution instrument out of calibration can report mass…
-
Coming back to: A community side-effect dataset, with its response rate and biases Replied, post #37 · Data & Tools › Datasets · 13 Mar 2026 · 7 likes Coming back to post #35, because the follow-up matters more than the original answer. Combining data from different sources: datasets from this site are not directly…
-
The lowest dose that does anything: is that a real question? Replied, post #96 · Practice › Dosing & titration · 7 Mar 2026 · 20 likes post #95 is right about the mechanism and I think understates the practical bit. Steady state means the plasma concentration is stable from dose to dose. That happens…
-
[2026 update] Amylin and gastric emptying: overlapping mechanisms with incretins Replied, post #21 · Compounds › Cagrilintide & amylin analogues · 3 Mar 2026 · 5 likes Nausea profile of amylin analogues: the historical agent pramlintide required multiple daily doses and had a difficult tolerability profile. A weekly formulation is a…
-
Second pass at: Where impurities in solid-phase peptide synthesis come from Replied, post #2 · Analytics › Impurities & related substances · 19 Feb 2026 · 0 likes On the opening post — agreed on the reasoning, with one qualification. Deletion sequences (incomplete coupling during synthesis): lower in mass by one residue.…
-
Coming back to: Training through a dose escalation week Replied, post #23 · Nutrition & Training › Resistance training · 6 Feb 2026 · 14 likes Recovery: heavier training on a energy deficit and on a compound that slows gastric emptying requires attention to recovery (sleep, nutrition, stress). Recovery…
-
[2026 update] What a purity-only report leaves out Replied, post #14 · Sourcing › Independent verification · 2 Feb 2026 · 32 likes On post #10 — agreed on the reasoning, with one qualification. When results are inconclusive: if a testing service reports "insufficient to verify" on a documentation…
-
Reused chromatograms across lots: how to spot it Replied, post #16 · Analytics › COA interpretation · 25 Jan 2026 · 6 likes Purity and content are different measurements: purity tells you what proportion of the detected material is the intended species. Content tells you how much of the…
-
Pregnancy and pregnancy planning: contraindication and washout Replied, post #23 · Clinical › Special populations · 25 Jan 2026 · 7 likes post #22 is right about the mechanism and I think understates the practical bit. Medullary thyroid carcinoma history: an absolute contraindication because of the…
-
Packaging that arrived damaged: documenting it properly — a second dataset Replied, post #14 · Sourcing › Logistics · 29 Dec 2025 · 4 likes post #13 answers the question as asked. The question underneath it is different. For anyone arriving from a search: the marked solution above is the direct answer, and…
-
Ultrasound and skinfolds: operator dependence in practice — what changed since Started this topic · Outcomes › Body composition · 11 Dec 2025 · 42 likes Posting this under the heading it deserves: Ultrasound and skinfolds: operator dependence in practice — what changed since Everything below is what sits behind that.…
-
Liver enzymes drifting down and what that usually means Replied, post #25 · Clinical › Bloodwork · 6 Nov 2025 · 0 likes HbA1c and glucose: HbA1c reflects average glucose over months; a spot glucose measurement reflects the moment. Trending glucose downward while HbA1c stays flat is a…
-
Coming back to: Why quantitation is the hard part, not detection Replied, post #87 · Analytics › Home & field testing · 31 Oct 2025 · 9 likes Picking up post #84: that is the part I would want checked first. Molecular tests: DNA or RNA tests are not applicable to peptides, which do not contain nucleic acids.…
-
Detection wavelength and why 214 nm and 280 nm disagree Replied, post #70 · Analytics › HPLC & UHPLC · 25 Oct 2025 · 0 likes Detection wavelength: 214 nm detects the peptide bond and is relatively insensitive to composition. 280 nm detects aromatic residues and is strongly…
-
The most useful thing you learned here that was not the answer you came for — a second… Replied, post #109 · Lounge › Off topic · 20 Oct 2025 · 12 likes Not a rules-free zone: the guidelines still apply. No phones, no Telegram, no endorsements of other communities. Just a relaxed bar for how directly the topic needs to…
-
What happens after your first post: likes, trust levels, and why none of it matters much… Replied, post #70 · Start Here › Welcome · 19 Oct 2025 · 0 likes Welcome. The orientation materials are pinned at the top of this category and they take about an hour. They answer most of the questions a new member has and they save…
-
Coming back to: A community side-effect dataset, with its response rate and biases Replied, post #29 · Data & Tools › Datasets · 5 Oct 2025 · 7 likes Collection methods: ask how the data were collected. Longitudinal tracking over months is stronger than retrospective recall. Prospective measurement (done while…
-
Compounds this community declines to help with, and why Replied, post #32 · Compounds › Other compounds · 29 Sep 2025 · 8 likes Sequence verification: for an obscure compound, a report of the amino acid sequence or a mass-spectrometry result confirming the mass is the only verification that…
-
The most useful thing you learned here that was not the answer you came for — a second… Replied, post #61 · Lounge › Off topic · 27 Sep 2025 · 30 likes Picking up post #58: that is the part I would want checked first. Personal stories: if you want to talk about what led you to this compound, your journey, or how the…
-
Reverse causation in a cohort study of weight and outcome — a second dataset Replied, post #25 · Evidence › Study critique · 13 Sep 2025 · 0 likes When you change your mind: if a reply convinces you that your criticism was not well-founded, say so plainly. The critique might still be real but smaller than you…
-
[2026 update] Does dual agonism explain the effect size, or is it dose? Replied, post #15 · Compounds › Tirzepatide · 8 Sep 2025 · 28 likes On post #11 — agreed on the reasoning, with one qualification. Half-life difference: tirzepatide is about 5 days versus semaglutide's week-long. Practically, that means…
-
A 10 mg vial reconstituted three different ways, compared — the long version Replied, post #108 · Practice › Reconstitution · 18 Aug 2025 · 0 likes Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can…
-
Coming back to: Why the cheapest option is often not the cheapest Replied, post #24 · Access › Pricing · 17 Jun 2025 · 0 likes Worth separating two things that post #20 runs together. Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did…
-
Insulin combinations and hypoglycaemia risk Replied, post #10 · Practice › Interactions · 16 Jun 2025 · 2 likes Coming back to post #8, because the follow-up matters more than the original answer. Thyroid medications: semaglutide is associated with a slowing of gastric emptying,…
-
Coming back to: Getting a referral rather than a refusal Replied, post #61 · Clinical › Prescriber conversations · 12 Jun 2025 · 4 likes Prescription logistics: confirm whether it will be filled locally, requires mail order, or will be prescribed off-label and needs a compounding pharmacy. Different…
-
Follow-up: Tracking intake honestly when appetite is absent Replied, post #55 · Nutrition & Training › Protein & intake · 10 Jun 2025 · 7 likes post #54 is right about the mechanism and I think understates the practical bit. Leucine and MPS: leucine stimulates muscle protein synthesis at a threshold of roughly…
-
[2026 update] US compounding rules and how they changed Replied, post #16 · Regional › North America · 30 May 2025 · 0 likes Worth separating two things that post #12 runs together. Compounding pharmacies: pharmaceutical compounding of a drug not on the FDA shortage list is substantially…
-
Lipase elevation without symptoms: the interpretation problem — a second dataset Replied, post #2 · Clinical › Bloodwork · 19 May 2025 · 0 likes On the opening post — agreed on the reasoning, with one qualification. Reference intervals: constructed to contain the central 95% of a reference population, which…
-
Coming back to: Sample size calculations, read backwards from the published number Replied, post #24 · Evidence › Trials · 11 May 2025 · 13 likes Coming back to post #22, because the follow-up matters more than the original answer. Risk of bias: structured appraisal of internal validity. Key things to assess:…
-
Journal club: STEP 4 and what a withdrawal design can prove — one year on Replied, post #62 · Evidence › Journal club · 27 Apr 2025 · 26 likes post #61 answers the question as asked. The question underneath it is different. For anyone arriving from a search: the marked solution above is the direct answer, and…
-
Journal club: SURMOUNT-4 and continuation versus withdrawal — a second dataset Replied, post #7 · Evidence › Journal club · 25 Mar 2025 · 3 likes This follows post #4 rather than contradicting it. SOUL (N Engl J Med 2025): Oral semaglutide cardiovascular outcomes. Extends the cardiovascular evidence to the oral…
-
Second pass at: Triple agonism: additive, synergistic, or neither? Replied, post #22 · Compounds › Retatrutide · 6 Mar 2025 · 3 likes Coming back to post #20, because the follow-up matters more than the original answer. Mass and identity: a report on retatrutide should state the mass detected by…
-
Obstructive sleep apnoea and a hard endpoint in this class Replied, post #27 · Clinical › Comorbidities · 6 Mar 2025 · 0 likes This follows post #24 rather than contradicting it. Comorbidity control: if a comorbidity (high blood pressure, high lipids) is not adequately controlled, the decision…
-
Pharmaceutical compounding rules, summarised from primary sources Started this topic · Sourcing › Regulatory · 26 Feb 2025 · 0 likes Pharmaceutical compounding rules, summarised from primary sources — setting out what I have, and where I think it stops being reliable. Structured report rather than an…
-
Contributing data without breaching anyone's privacy — what changed since Replied, post #3 · Data & Tools › Datasets · 15 Feb 2025 · 13 likes post #2 answers the question as asked. The question underneath it is different. Using data in discussions: datasets are useful as reference points when someone claims…
-
When "no data" is the complete and final answer Replied, post #91 · Compounds › Other compounds · 13 Feb 2025 · 1 like How to research a compound with no human data: mechanistic plausibility is one input. Preclinical data is another. The honest position is that you are reasoning from…
-
Reporting a good result: why nobody bothers and why they should — one year on Replied, post #26 · Sourcing › Vendor reports · 25 Jan 2025 · 4 likes Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
-
Body image changing more slowly than the body Replied, post #107 · Wellbeing › Mental health · 23 Dec 2024 · 6 likes Body image and weight loss: large weight loss changes a person's relationship with their body in ways that can be psychologically complex. Some of that is positive;…
-
Fixed versus detachable needles: the trade-offs Replied, post #42 · Devices › Syringes & needles · 10 Dec 2024 · 12 likes Fixed versus detachable needles: insulin syringes usually have fixed needles (no dead volume loss to the hub). Luer-lock syringes use detachable needles (more dead…
-
Meeting a protein target on a suppressed appetite — does this still hold? Replied, post #46 · Nutrition & Training › Protein & intake · 9 Dec 2024 · 0 likes Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can…
-
Reporting a good result: why nobody bothers and why they should — one year on Replied, post #2 · Sourcing › Vendor reports · 27 Oct 2024 · 18 likes Worth separating two things that the opening post runs together. Date the report: when the analysis was done matters. Material can degrade in storage. A report from two…
-
SURPASS-2 and the comparator dose question that will not go away Replied, post #34 · Compounds › Tirzepatide · 14 Oct 2024 · 21 likes I read post #32 twice before replying, because I had assumed the opposite. SURMOUNT-4 used a randomised withdrawal design: everyone titrated, then those on maintenance…
-
Second pass at: Hoarding and why it makes a shortage worse Replied, post #124 · Access › Shortages · 13 Oct 2024 · 27 likes Shortage predictions: regulators and suppliers issue shortage alerts before they become acute. Checking the regulatory website for shortages gives you advance notice.
-
Revisiting: How to bring a laboratory report to an appointment usefully Replied, post #99 · Clinical › Bloodwork · 11 Oct 2024 · 1 like HbA1c and glucose: HbA1c reflects average glucose over months; a spot glucose measurement reflects the moment. Trending glucose downward while HbA1c stays flat is a…
-
Second pass at: Hoarding and why it makes a shortage worse Replied, post #53 · Access › Shortages · 11 Oct 2024 · 1 like Patient advocacy during shortages: some advocacy groups advocate for patients during shortages. Knowing who they are and following their communication is useful.
-
Orforglipron as a non-peptide: what changes when the molecule is small Replied, post #9 · Compounds › Oral incretins · 26 Aug 2024 · 24 likes Picking up post #6: that is the part I would want checked first. PIONEER programme is phase 3 for oral semaglutide. The trials cover multiple indications and durations.…
-
Circumference measurements as a poor man's composition estimate Replied, post #76 · Outcomes › Body composition · 18 Aug 2024 · 30 likes post #75 answers the question as asked. The question underneath it is different. Precision versus accuracy: the precision you need depends on what question you are…
-
Follow-up: Conditions that change the calculus rather than forbidding it Replied, post #22 · Safety › Contraindications · 21 Jul 2024 · 0 likes Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can…
-
Oral contraceptives and delayed emptying: what the data shows Replied, post #17 · Practice › Interactions · 8 Jul 2024 · 0 likes Metformin: commonly co-administered and relevant to gastrointestinal tolerability. Gastrointestinal side effects can overlap and additive. Taking them separately or…